Cambrex在今天制造业的文章中

东卢瑟福,NJ -Cambrex Corporation(纽约证券交易所代码:CBM,“Cambrex”)在2010年夏季的制造业杂志中展出。文章,良好的化学:凸轮幕后的技术进步在Cambrex有助于降低制造商的风险,提供Cambrex历史,制造能力,地点和最近收购的深入概述。

The article discusses how, even in the highly-regulated pharmaceutical marketplace, Cambrex’s manufacturing technologies, quality and process systems successfully operate in compliance with laws and policies enforced not only by regulatory agencies including the Food and Drug Administration (“FDA”) and the Drug Enforcement Administration (“DEA”), but also by customers.

高效活性药物成分(“HPAPI”)开发和制造,引用药物递送和生物分析作为Cambrex如何获得高度专业化能力来区分竞争对手的示例。这些功能将Cambrex放在API制造技术的最前沿,并为客户提供可能导致其项目的成本和质量优势的技术。In addition, Cambrex’s novel Continuous-Flow Microwave-Assisted Organic Synthesis (“CF-MAOS”) technology was highlighted for its innovative, scalable and efficient capabilities in using microwave technology in a continuous manufacturing arrangement that results in yield, quality and cost improvements to processes for manufacturing APIs.

根据它网站数字和印刷品杂志提供其36,000名读者,其中包括来自制造业所有领域的最佳实践的案例研究和策略。

Cambrex今天制造业的文章可以是在线查看

Cambrex图标
由Cambrex发布
标签